Cryptogenic stroke patients with patent foramen ovale should be closed only in the setting of a randomized control trial.
Felberg
Robert A
RA
Department of Neurology, Ochsner Foundation Hospital, New Orleans, Louisiana, USA. Rfelberg@ochsner.org
D019320:Embolism, Paradoxical / Q000150:complications* / Q000517:prevention & control*; D006344:Heart Septal Defects, Atrial / Q000150:complications* / Q000628:therapy*; D006801:Humans; D018579:Patient Selection; D016032:Randomized Controlled Trials as Topic; D020521:Stroke / Q000209:etiology* / Q000517:prevention & control*